Treatment of Cytomegalovirus Retinitis in Patients with the Acquired Immunodeficiency Syndrome
- 10 July 1997
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (2) , 105-114
- https://doi.org/10.1056/nejm199707103370207
Abstract
Until recently, long-term regimens consisting of daily intravenous infusions of ganciclovir or foscarnet were the only available treatments for patients with cytomegalovirus (CMV) retinitis, a sight-threatening complication that affects approximately one third of patients in the United States with the acquired immunodeficiency syndrome (AIDS).1,2 In the past three years, the results of 11 randomized clinical trials of four new treatments for AIDS-related CMV retinitis have been reported.313 Thus, there are now new therapies from which clinicians can choose.Incidence and Natural History of CMV RetinitisCMV end-organ disease has emerged as one of the most common serious complications . . .Keywords
This publication has 71 references indexed in Scilit:
- Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir ImplantNew England Journal of Medicine, 1997
- CidofovirDrugs, 1996
- Susceptibility of Human Cytomegalovirus to Cidofovir Is Unchanged after Limited In Vivo Exposure to Various Clinical Regimens of DrugThe Journal of Infectious Diseases, 1996
- Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patientsClinical Therapeutics, 1995
- Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDSAIDS, 1995
- Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antiviralsClinical and Diagnostic Virology, 1993
- Activity of different antiviral drug combinations against human cytomegalovirus replication in vitroEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Ganciclovir with recombinant methionyl human granulocyte colony-stimulating factor for treatment of cytomegalovirus disease in AIDS patientsAIDS, 1992
- Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus RetinitisNew England Journal of Medicine, 1992
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986